Monday - December 23, 2024

Non-Sedating Dexmedetomidine Treatment Regimens

2024-11-12

ALEXANDRIA, Virginia, Nov. 12 -- BIOXCEL THERAPEUTICS, INC., New Haven, Connecticut has been assigned a patent (No. US 12138247 B2, initially filed March 8, 2024) developed by six inventors Vasukumar Kakumanu, New Haven, Connecticut; David Christian Hanley, New Haven, Connecticut; Frank Yocca, New Haven, Connecticut; Chetan Dalpatbhai Lathia, New Haven, Connecticut; Lavanya Rajachandran, New Haven, Connecticut; and Robert Risinger, New Haven, Connecticut, for "Non-sedating dexmedetomidine treat . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Non-Sedating Dexmedetomidine Treatment Regimens

Information Request Form

Copyright Targeted News Service 2024